Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer ; volume:9 ; number:1 ; day:12 ; month:2 ; year:2019 ; pages:1-6 ; date:12.2019
Scientific reports ; 9, Heft 1 (12.2.2019), 1-6, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Martin, Nikolas Tim
Roy, Dominic Guy
Workenhe, Samuel Tekeste
van den Wollenberg, Diana J. M.
Hoeben, Rob C.
Mossman, Karen Louise
Bell, John Cameron
Bourgeois-Daigneault, Marie-Claude
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-38385-7
- URN
-
urn:nbn:de:101:1-2019031123500016337037
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martin, Nikolas Tim
- Roy, Dominic Guy
- Workenhe, Samuel Tekeste
- van den Wollenberg, Diana J. M.
- Hoeben, Rob C.
- Mossman, Karen Louise
- Bell, John Cameron
- Bourgeois-Daigneault, Marie-Claude
- SpringerLink (Online service)
Other Objects (12)
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy